ABEO · Company research
Abeona Therapeutics Inc. (ABEO): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
18records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO | Pomerantz LLP is investigating potential securities fraud claims against Abeona Therapeutics following the company's August 13, 2026 disclosure that only four of five patient treatments with ZEVASKYN were recognized for revenue due to one batch lacking minimum sheet requirements. The announcement triggered a 14.95% stock price decline. | View source ↗ | GlobeNewswire Inc. | Oct 6, 2026 | bearish | -1 | 1 |
| INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO | Pomerantz LLP is investigating potential securities fraud claims against Abeona Therapeutics following the company's August 13, 2026 disclosure that only four of five patient treatments with ZEVASKYN were recognized for revenue due to one batch lacking minimum sheet requirements. The announcement triggered a 14.95% stock price decline. | View source ↗ | GlobeNewswire Inc. | Oct 6, 2026 | bearish | -1 | 1 |
| Abeona Therapeutics Inc. (ABEO) stock price, news, quote and history - Yahoo Finance Australia | Abeona Therapeutics Inc. (ABEO) stock price, news, quote and history Yahoo Finance Australia | View source ↗ | Yahoo Finance Australia | Oct 3, 2026 | neutral | 0 | 0.6 |
| Abeona Therapeutics Stock Price Forecast. Should You Buy ABEO? - StockInvest.us | Abeona Therapeutics Stock Price Forecast. Should You Buy ABEO? StockInvest.us | View source ↗ | StockInvest.us | Oct 2, 2026 | neutral | 0 | 0.6 |
| Two new hires' awards cover up to 7,200 Abeona shares, which become theirs over three years if they stay. - Stock Titan | Two new hires' awards cover up to 7,200 Abeona shares, which become theirs over three years if they stay. Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| To cover stock-award taxes, Abeona Therapeutics (ABEO) legal chief sold 6,727 shares. - Stock Titan | To cover stock-award taxes, Abeona Therapeutics (ABEO) legal chief sold 6,727 shares. Stock Titan | View source ↗ | Stock Titan | Sep 30, 2026 | neutral | 0 | 0.6 |
| To cover stock-award taxes, Abeona Therapeutics (ABEO) officer sold 4,902 shares. - Stock Titan | To cover stock-award taxes, Abeona Therapeutics (ABEO) officer sold 4,902 shares. Stock Titan | View source ↗ | Stock Titan | Sep 29, 2026 | neutral | 0 | 0.6 |
| To cover stock-award taxes, Abeona Therapeutics (ABEO) CFO sells 9,191 shares. - Stock Titan | To cover stock-award taxes, Abeona Therapeutics (ABEO) CFO sells 9,191 shares. Stock Titan | View source ↗ | Stock Titan | Sep 29, 2026 | neutral | 0 | 0.6 |
| To cover stock-award taxes, Abeona Therapeutics (ABEO) CEO sells 19,608 shares. - Stock Titan | To cover stock-award taxes, Abeona Therapeutics (ABEO) CEO sells 19,608 shares. Stock Titan | View source ↗ | Stock Titan | Sep 29, 2026 | neutral | 0 | 0.6 |
| Abeona Therapeutics (NasdaqCM:ABEO) Stock Forecast & Analyst Predictions - Simply Wall Street | Abeona Therapeutics (NasdaqCM:ABEO) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Sep 28, 2026 | neutral | 0 | 0.6 |
| ABEO Stock Gains On Approval For A Drug Abeona Sold, Rating For The One It Sells - Stocktwits | ABEO Stock Gains On Approval For A Drug Abeona Sold, Rating For The One It Sells Stocktwits | View source ↗ | Stocktwits | Sep 17, 2026 | neutral | 0 | 0.6 |
| Abeona Therapeutics (ABEO) Stock Faces Early Launch Strain Despite Revenue Traction - Simply Wall Street | Abeona Therapeutics (ABEO) Stock Faces Early Launch Strain Despite Revenue Traction Simply Wall Street | View source ↗ | Simply Wall Street | Aug 14, 2026 | neutral | 0 | 0.6 |
| Abeona stock drops after Q2 revenue miss (ABEO:NASDAQ) - Seeking Alpha | Abeona stock drops after Q2 revenue miss (ABEO:NASDAQ) Seeking Alpha | View source ↗ | Seeking Alpha | Aug 13, 2026 | neutral | 0 | 0.6 |
| Abeona Q2 Revenue Rises 31% to $11.4 Million | ABEO Stock News - Quiver Quantitative | Abeona Q2 Revenue Rises 31% to $11.4 Million | ABEO Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 13, 2026 | neutral | 0 | 0.6 |
| $ABEO stock is down 12% today. Here's what we see in our data. - Quiver Quantitative | $ABEO stock is down 12% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 13, 2026 | neutral | 0 | 0.6 |
| Abeona Therapeutics: Earnings Sell-Off Could Be A Buy Opportunity (NASDAQ:ABEO) - Seeking Alpha | Abeona Therapeutics: Earnings Sell-Off Could Be A Buy Opportunity (NASDAQ:ABEO) Seeking Alpha | View source ↗ | Seeking Alpha | Aug 13, 2026 | neutral | 0 | 0.6 |
| Abeona will stream its Q2 financial update on Aug. 13 - Stock Titan | Abeona will stream its Q2 financial update on Aug. 13 Stock Titan | View source ↗ | Stock Titan | Aug 6, 2026 | neutral | 0 | 0.6 |
| Insider Sale: Director at $ABEO Sells 18,160 Shares - Quiver Quantitative | Insider Sale: Director at $ABEO Sells 18,160 Shares Quiver Quantitative | View source ↗ | Quiver Quantitative | Jun 16, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.